Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Rakovina Therapeutics Inc. has announced that some debenture holders have chosen to receive common shares instead of cash as part of their interest payment, amounting to approximately $20,500. The issuance of these shares is contingent upon the discounted market price and necessary approvals from the TSX Venture Exchange.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
